Trials / Completed
CompletedNCT02523820
Nebulized Corticosteroid for Post Extubation Stridor in Children
Nebulized Corticosteroid for Post Extubation Stridor in Children: A Randomized Double Blind Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 144 (actual)
- Sponsor
- Ramathibodi Hospital · Academic / Other
- Sex
- All
- Age
- 1 Month – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and adverse effect of nebulized corticosteroid to prevent post-extubation stridor in children.
Detailed description
The guideline for prevention and treatment of post-extubation stridor in children is inconclusive include Nebulized epinephrine and intravenous corticosteroid. Nebulized corticosteroid is alternative treatment for viral croup. the rationale of this study to evaluate the efficacy of nebulized fluticasone propionate to prevent pediatric post-extubation stridor
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fluticasone propionate | Flixotide 1 mg + NSS upto 4 ml nebulized after extubation. Record vital signs and modified Westley score at 0, 15, 30, 60 min and 2,4,6 hours |
| DRUG | Placebo | NSS 4 ml nebulized after extubation. Record vital signs and modified Westley score at 0, 15, 30, 60 min and 2,4,6 hours |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-05-30
- Completion
- 2016-08-30
- First posted
- 2015-08-14
- Last updated
- 2017-04-27
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT02523820. Inclusion in this directory is not an endorsement.